“ID:2037 Molecular Mechanisms Underlying Resistance to MEK1 2 Inhibitor in BRAF-Mutated Colorectal Cancer”. Biomedical Research and Therapy, vol. 4, no. S, Sept. 2017, p. S68, https://doi.org/10.15419/bmrat.v4iS.276.